GFACX
Price
$57.16
Change
-$3.41 (-5.63%)
Updated
Apr 3 closing price
Net Assets
279.82B
MFEHX
Price
$158.47
Change
-$9.39 (-5.59%)
Updated
Apr 3 closing price
Net Assets
42.45B
Ad is loading...

GFACX vs MFEHX

Header iconGFACX vs MFEHX Comparison
Open Charts GFACX vs MFEHXBanner chart's image
American Funds Growth Fund of Amer C
Price$57.16
Change-$3.41 (-5.63%)
VolumeN/A
Net Assets279.82B
MFS Growth R3
Price$158.47
Change-$9.39 (-5.59%)
VolumeN/A
Net Assets42.45B
GFACX vs MFEHX Comparison Chart
Loading...
View a ticker or compare two or three
VS
GFACX vs. MFEHX commentary
Apr 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GFACX is a Hold and MFEHX is a StrongBuy.

Ad is loading...
FUNDAMENTALS
Fundamentals
GFACX has more cash in the bank: 280B vs. MFEHX (42.4B). GFACX (0.00) and MFEHX (0.00) have matching dividends . GFACX was incepted earlier than MFEHX: GFACX (24 years) vs MFEHX (20 years). GFACX (1.36) is less costly to investors than MFEHX (0.86). MFEHX is a more actively managed with annual turnover of: 33.00 vs. GFACX (25.00). MFEHX has a lower initial minimum investment than GFACX: MFEHX (0) vs GFACX (250). GFACX annual gain was more profitable for investors over the last year : -1.75 vs. MFEHX (-7.80). MFEHX return over 5 years is better than : 66.98 vs. GFACX (59.73).
GFACXMFEHXGFACX / MFEHX
Total Expense Ratio1.360.85160%
Annual Report Gross Expense Ratio1.360.86158%
Fund Existence24 years20 years-
Gain YTD-5.003-7.41867%
Front LoadN/AN/A-
Min. Initial Investment2500-
Min. Initial Investment IRAN/AN/A-
Net Assets280B42.4B660%
Annual Yield % from dividends0.000.00-
Returns for 1 year-1.75-7.8022%
Returns for 3 years0.635.0413%
Returns for 5 years59.7366.9889%
Returns for 10 years44.46138.2032%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
OTLY9.54-0.41
-4.12%
Oatly Group AB
INDP0.47-0.03
-5.24%
Indaptus Therapeutics
VTRS8.16-0.50
-5.77%
Viatris
GDRX4.29-0.28
-6.13%
GoodRx Holdings
KOD2.40-0.27
-10.11%
Kodiak Sciences